In fall 2020, MIT’s School of Engineering and Takeda Pharmaceuticals Company Limited launched the MIT-Takeda Program, a collaboration to support members of the MIT community working at the intersection of artificial intelligence and human health. Hou
The 2021-22 Takeda Fellows are working on research involving electronic health record algorithms, remote sensing data as it relates to environmental health risk, and neural networks for the development of antibiotics.
MIT researchers have developed a deep learning model that can rapidly predict the likely 3D shapes of a molecule given a 2D graph of its structure. This technique could accelerate drug discovery by narrowing down the number of molecules pharmaceutical researchers need to test in lab experiments.
In their quest to discover effective new medicines, scientists search for drug-like molecules that can attach to disease-causing proteins and change their